Prot# 20050253: A Multicenter, Open-label, Single Agent, Two-stage Phase 2 Study to Evaluate the Efficacy and Safety of AMG 102 in Subjects with Advanced Malignant Glioma

  • Raizer, Jeffrey J (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/22/06 → 2/1/12

Funding

  • Amgen, Inc. (20050253)